Loading...
Loading...
Among the 4 tracked institutional investors we monitor, QNCX (QUINCE THERAPEUTICS INC) is held with a combined value of $8.39M across 2,183,596 shares. The largest holder is VANGUARD GROUP INC with a position worth $6.98M. 3 funds opened new positions in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$8.39M
Total Shares Held
2,183,596
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $6.98M | 0.00% | +18.2% |
| 2 | MILLENNIUM MANAGEMENT LLC | $1.29M | 0.00% | New |
| 3 | TWO SIGMA ADVISERS, LP | $90.78K | 0.00% | New |
| 4 | BlackRock, Inc. | $30.96K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of QNCX with a position worth $6.98M, representing 0.00% of their portfolio. In total, 4 institutional investors hold QNCX with a combined value of $8.39M.
In the most recent quarter, 3 funds opened a new position in QNCX. Additionally, 1 increased their holdings.
Institutional investors hold $8.39M worth of QNCX stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $6.98M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For QNCX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their QNCX positions.
| 2026-10-14 |
| 9.0% | 2026-08-14 |
| — | 2026-08-14 |
| 10.0% | 2026-08-14 |
| 10.0% | 2026-08-14 |
| 5.6% | 2026-08-04 |
SEC Schedule 13D (activist) and 13G (passive) filings for QNCX. Filed when an investor acquires 5%+ ownership.
Last Close
$34.68
2026-10-21
YTD
+83.7%
75% of 52-week range